Journal of Cardiac Surgery最新文献

筛选
英文 中文
Alfieri Stitch (Edge To Edge) in Degenerative Mitral Valve Repair: Characteristics and Late Durability in 648 Patients Alfieri针(边缘到边缘)在退行性二尖瓣修复中的应用:648例患者的特征和后期耐久性
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2025-01-07 DOI: 10.1155/jocs/6839315
Brittany A. Zwischenberger, Jeffrey G. Gaca, Keith Carr, Caitlin Cosme, Muath Bishawi, Andrew Wang, Donald D. Glower
{"title":"Alfieri Stitch (Edge To Edge) in Degenerative Mitral Valve Repair: Characteristics and Late Durability in 648 Patients","authors":"Brittany A. Zwischenberger,&nbsp;Jeffrey G. Gaca,&nbsp;Keith Carr,&nbsp;Caitlin Cosme,&nbsp;Muath Bishawi,&nbsp;Andrew Wang,&nbsp;Donald D. Glower","doi":"10.1155/jocs/6839315","DOIUrl":"https://doi.org/10.1155/jocs/6839315","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Mitral valve repair with the edge-to-edge technique (Alfieri stitch) has been described for over 20 years, yet little is published on late durability and potential risk of mitral stenosis remains controversial. The primary objective of this study is to describe characteristics and late durability of Alfieri stitch in mitral valve repair.</p>\u0000 <p><b>Methods:</b> From 2004 to 2019, we reviewed data from our prospectively maintained institutional database on 1175 consecutive patients with degenerative mitral regurgitation (MR) who underwent repair. Patients undergoing concomitant operations were included. Propensity score matching was performed on patients with and without Alfieri stitch to compare clinical (survival and reoperation) and echocardiographic (moderate or severe MR [“moderate or more MR”], severe MR, and mitral stenosis) outcomes up to 10 years.</p>\u0000 <p><b>Results:</b> Overall, 1175 patients underwent mitral valve repair; 55.1% (<i>n</i> = 648) received the Alfieri stitch. The median follow-up was 4.7 (2.0, 8.2) years. Matched patients with and without Alfieri stitch had similar cumulative incidence (CI) of moderate or more MR (24% ± 5% vs. 17% ± 4%, <i>p</i> = 0.2, respectively), severe MR (5% ± 2% vs. 4% ± 2%, <i>p</i> = 0.3), and mitral reoperation (9% ± 3% vs. 2% ± 1%, <i>p</i> = 0.06) with no difference in survival (84% ± 3% vs. 81% ± 3%, <i>p</i> = 0.2). The Alfieri stitch resulted in a slightly higher mean mitral valve gradient (3.9% ± 1.5 mmHg vs. 3.6% ± 1.6 mmHg, <i>p</i> = 0.0003). The CI of mitral stenosis at 10 years was negligible (one patient with Alfieri stitch and two patients without Alfieri stitch).</p>\u0000 <p><b>Conclusions:</b> In selected patients with degenerative mitral regurgitation, mitral valve repair with Alfieri stitch is durable with late outcomes comparable with other repair techniques. The Alfieri stitch may be a useful tool in selecting complex mitral pathology with minimal increased incidence of mitral stenosis. Further investigation is needed to delineate best indications for the use of Alfieri stitch.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2025 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jocs/6839315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143112778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Results of Minimally Invasive Mitral Valvuloplasty: Insights From a 12-Year Single-Center Experience 微创二尖瓣成形术的长期结果:来自12年单中心经验的见解
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2025-01-03 DOI: 10.1155/jocs/7846083
Chiaki Aichi, Mototsugu Tamaki, Yusuke Imamura, Yuichiro Fukumoto, Hideki Kitamura
{"title":"Long-Term Results of Minimally Invasive Mitral Valvuloplasty: Insights From a 12-Year Single-Center Experience","authors":"Chiaki Aichi,&nbsp;Mototsugu Tamaki,&nbsp;Yusuke Imamura,&nbsp;Yuichiro Fukumoto,&nbsp;Hideki Kitamura","doi":"10.1155/jocs/7846083","DOIUrl":"https://doi.org/10.1155/jocs/7846083","url":null,"abstract":"<div>\u0000 <p><b>Purpose:</b> The safety and long-term durability of minimally invasive mitral valvuloplasty (MIMVP) remain controversial. This study aimed to compare the perioperative and long-term outcomes of minimally invasive mitral valve surgery (MIMVS) and conventional sternotomy.</p>\u0000 <p><b>Methods:</b> This study included 476 patients who underwent mitral valve surgeries at our institution between January 2011 and December 2023. Patients were classified according to whether they underwent sternotomy: the nonsternotomy (NS: 271 cases) and sternotomy (S: 205 cases) groups. Perioperative and long-term outcomes were compared between the two groups.</p>\u0000 <p><b>Results:</b> The NS group had a lower preoperative age and EuroScore II. In the S group, the left ventricular ejection fraction was lower, while the left ventricular end-systolic diameter and left atrial diameter were larger. Operative time, cardiopulmonary bypass time, and aortic cross-clamp time were longer in the NS group. Postoperative atrial fibrillation, more transfusion, and increased length of hospital stay were more frequent in the S group. The 10-year freedom from reoperation and 10-year survival rates in the NS and S groups were 98.1% vs. 93.6% (<i>p</i> = 0.07) and 94.8% vs. 86.9%, respectively (<i>p</i> = 0.08), with no significant differences.</p>\u0000 <p><b>Conclusion:</b> MIMVP demonstrates noninferior perioperative and long-term outcomes compared with conventional sternotomy.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2025 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jocs/7846083","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143111207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of 30-Day Mortality by the Harborview Risk Score in Ruptured Abdominal Aortic Aneurysm: Systematic Review and Meta-Analysis 用 Harborview 风险评分预测腹主动脉瘤破裂患者的 30 天死亡率:系统回顾和元分析
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-12-19 DOI: 10.1155/jocs/4783571
Qingpeng Song, Maohua Wang, Zhengtong Zhou, Zhengkun Huo, Bi Cong, Chuanle Wang, Hao Guo, Yifan Guo, Xuejun Wu
{"title":"Prediction of 30-Day Mortality by the Harborview Risk Score in Ruptured Abdominal Aortic Aneurysm: Systematic Review and Meta-Analysis","authors":"Qingpeng Song,&nbsp;Maohua Wang,&nbsp;Zhengtong Zhou,&nbsp;Zhengkun Huo,&nbsp;Bi Cong,&nbsp;Chuanle Wang,&nbsp;Hao Guo,&nbsp;Yifan Guo,&nbsp;Xuejun Wu","doi":"10.1155/jocs/4783571","DOIUrl":"https://doi.org/10.1155/jocs/4783571","url":null,"abstract":"<div>\u0000 <p><b>Introduction:</b> Ruptured abdominal aortic aneurysm (RAAA) is a very severe condition with 17.4%–45.1% 30-day mortality rates. The 30-day death prediction model for patients with RAAA is one of the most significant models developed by Harborview Medical Center (HMC). The Harborview Risk Score (HRS) was calculated using the following four preoperative factors: minimum systolic blood pressure, age, Pondus Hydrogenii (pH), and creatinine (Cr). The objective was to evaluate the validity and dependability of the HMC model for predicting 30-day mortality with a large data sample.</p>\u0000 <p><b>Methods:</b> The medical subject heading (MeSH) was used to search the electronic database. Four key indicators, the 30-day mortality rate, and the HRS score were among the data that were retrieved. The inclusion criteria include RAAA patients, applying the HMC prediction model and with baseline data, and the exclusion criteria include other prediction models and studies with incomplete baseline data from patients.</p>\u0000 <p><b>Results:</b> There were 2931 participants in total throughout 7 trials; 1536 of these patients came from the National Surgical Quality Improvement Program (NSQIP) database, and the other patients came from single center in each project. Thirty-day mortality was 34.9% (95% CI: 0.27–0.33) on average. The majority of the patients (<i>n</i> = 2616, 89.25%) had an HRS score of 0–2. All patients who had a score of 4 died, no matter which single center they were in. Furthermore, with every extra point that a patient with a score of 0–3 received, their death rate rose by around 15%–20%.</p>\u0000 <p><b>Conclusion:</b> The HMC prediction model is a trustworthy prediction model that can more simply and accurately predict 30-day postoperative mortality through the use of age, pH, Cr, and minimum systolic blood pressure. It also provides more preoperative counsel and assessment to the patient, family, and physician.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jocs/4783571","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142861927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redo Aortic Root Replacement After Prior Modified Inclusion Versus Total Aortic Root Replacement 先前改良纳入后重做主动脉根部置换与全主动脉根部置换
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-12-02 DOI: 10.1155/jocs/3525884
Alexander Makkinejad, Xiaoting Wu, Karen Kim, Shinichi Fukuhara, Himanshu Patel, Gorav Ailawadi, Bo Yang
{"title":"Redo Aortic Root Replacement After Prior Modified Inclusion Versus Total Aortic Root Replacement","authors":"Alexander Makkinejad,&nbsp;Xiaoting Wu,&nbsp;Karen Kim,&nbsp;Shinichi Fukuhara,&nbsp;Himanshu Patel,&nbsp;Gorav Ailawadi,&nbsp;Bo Yang","doi":"10.1155/jocs/3525884","DOIUrl":"https://doi.org/10.1155/jocs/3525884","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> There is currently little data in the literature evaluating the long-term outcomes of reoperative aortic root replacement after previous aortic root replacement, and there are no studies comparing how these outcomes differ based on the approach of the initial aortic root replacement. Our objective was to determine the outcomes of reoperative aortic root replacement following prior aortic root replacement with either the total root or inclusion root techniques.</p>\u0000 <p><b>Methods:</b> This study was a retrospective cohort analysis of 260 patients who underwent redo aortic root replacement from September 1994 to July 2024. Previous root replacements were done with the total root technique in 90 patients and inclusion root technique in 170 patients. The primary outcomes of the study were perioperative complications, operative mortality, and late survival.</p>\u0000 <p><b>Results:</b> The median age of the entire cohort was 57 years, and 79% were males. The prior total root group was younger, had more Marfan syndrome, and more concomitant ascending/arch replacement. Perioperatively, the groups had similar recovery times and complication rates, though there was more postoperative sepsis in the prior total root group (5.6% vs. 0.6%), Operative mortality was 4.2% in the whole cohort; 5.6% in the total root group versus 3.5% in the inclusion root group, <i>p</i> = 0.44. Survival at 5 and 10 years was 84% and 70% in the whole cohort, respectively. The 5-year survival was similar between the groups at 81% in the total root group and 85% in the inclusion root group, <i>p</i> = 0.82. Cox proportional hazards regression showed infection as a primary indication and was a significant risk factor for late mortality (hazard ratio 2.55 [95% CI: 1.45, 4.50], <i>p</i> = 0.001), as was diabetes (HR: 2.00 [95% CI: 1.04, 3.82], <i>p</i> = 0.037), but previous total root versus inclusion root procedure was not (hazard ratio 1.10 [95% CI: 0.58, 2.09], <i>p</i> = 0.77).</p>\u0000 <p><b>Conclusions:</b> Reoperative aortic root replacement following prior root replacement can be performed with good short- and long-term outcomes after either total root or inclusion root replacement.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jocs/3525884","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142759857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Resection of a Big Hemolymphangioma of the Left Atrial Appendage With 8 Years of Follow-Up 成功切除左心房阑尾大血肿并随访 8 年
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-11-18 DOI: 10.1155/jocs/5690794
Zhixiong Huang
{"title":"Successful Resection of a Big Hemolymphangioma of the Left Atrial Appendage With 8 Years of Follow-Up","authors":"Zhixiong Huang","doi":"10.1155/jocs/5690794","DOIUrl":"https://doi.org/10.1155/jocs/5690794","url":null,"abstract":"<div>\u0000 <p>Hemolymphangiomas of the heart are one of the rarest types of cardiac tumors. We describe the case of a 63-year-old woman with a large hemolymphangioma arising from the left atrial appendage. Complete resection of this rare tumor was performed successfully, with no tumor recurrence during the 8-year follow-up.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jocs/5690794","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chest Tube Clearance Strategies Versus Conventional Chest Tubes After Cardiac Surgery 心脏手术后胸管清创策略与传统胸管相比
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-11-04 DOI: 10.1155/2024/2207185
Veronica F. Chan, Dominique Vervoort, Derrick Y. Tam, Stephen E. Fremes
{"title":"Chest Tube Clearance Strategies Versus Conventional Chest Tubes After Cardiac Surgery","authors":"Veronica F. Chan,&nbsp;Dominique Vervoort,&nbsp;Derrick Y. Tam,&nbsp;Stephen E. Fremes","doi":"10.1155/2024/2207185","DOIUrl":"https://doi.org/10.1155/2024/2207185","url":null,"abstract":"<div>\u0000 <p>Standard chest tubes (CTs) used to drain retained blood can become occluded from blood clots, leading to ineffective drainage and postoperative complications such as cardiac tamponade. Chest tube clearance strategies (CTCSs) were developed to improve CT patency. Our meta-analysis compared the safety and efficacy of CTCS versus CT following cardiac surgery. The PubMed/MEDLINE, Embase, Web of Science, and Scopus databases were searched from 1946 to 2023 for studies that compared CTCS to CT. Two investigators independently reviewed, screened, extracted, and assessed the data prior to performing a random effects meta-analysis using R. The primary outcome was re-exploration and the secondary outcomes were retained blood syndrome, mortality, blood products, stroke, cardiac arrest, atrial fibrillation, ventilation time, intensive care unit (ICU) time, hospital length of stay, and chest drainage. Five studies (2288 patients) were included. There were two clinical trials (<i>n</i> = 620) and three observational studies (1668 patients). Compared to CT, CTCS had a significant reduction of postoperative atrial fibrillation (risk ratio (RR) 0.80, 95% CI 0.70 to 0.92, <i>I</i><sup>2</sup> = 17%, <i>p</i> &lt; 0.01). There was no significant difference in re-exploration, retained blood syndrome, hospital length of stay, and ICU length of stay. However, with the addition of four unmatched studies (<i>n</i> = 2583), CTCS was associated with a significant reduction in re-exploration (RR 0.52, 95% CI 0.37 to 0.73, <i>I</i><sup>2</sup> = 34%, <i>p</i> &lt; 0.01), retained blood syndrome (RR 0.71, 95% CI 0.53 to 0.95, <i>I</i><sup>2</sup> = 72%, <i>p</i> = 0.02), hospital length of stay (mean difference (MD) −0.40, 95% CI −0.78 to −0.01, <i>I</i><sup>2</sup> = 49%, <i>p</i> = 0.04), and chest drainage (MD 0.80, 95% CI 0.70 to 0.92, <i>I</i><sup>2</sup> = 17%, <i>p</i> &lt; 0.01). Drawing from results including the unmatched studies, CTCSs are associated with fewer postoperative complications compared to CT. This was achieved without major differences in chest drainage, supporting the important role of preventing even small accumulations of blood in the pericardial space.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/2207185","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142579616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Survival of Mitroflow and Perimount Aortic Valve Replacements Mitroflow 和包膜主动脉瓣置换术的长期存活率
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-11-01 DOI: 10.1155/2024/6712990
Lytfi Krasniqi, Jordi Sanchez Dahl, Christian Greve Jensen, Poul Erik Mortensen, Axel Brandes, Oke Gerke, Emil Johannes Ravn, Viktor Poulsen, Lars Peter Schødt Riber
{"title":"Long-Term Survival of Mitroflow and Perimount Aortic Valve Replacements","authors":"Lytfi Krasniqi,&nbsp;Jordi Sanchez Dahl,&nbsp;Christian Greve Jensen,&nbsp;Poul Erik Mortensen,&nbsp;Axel Brandes,&nbsp;Oke Gerke,&nbsp;Emil Johannes Ravn,&nbsp;Viktor Poulsen,&nbsp;Lars Peter Schødt Riber","doi":"10.1155/2024/6712990","DOIUrl":"https://doi.org/10.1155/2024/6712990","url":null,"abstract":"<div>\u0000 <p><b>Objectives:</b> The American College of Cardiology (ACC) guidelines recommend the same imaging frequency for all bioprosthetic valves, but some have demonstrated poor durability. We aimed to assess mortality differences between small (19–21 mm) and large (23–29 mm) in Mitroflow and Carpentier-Edwards Perimount aortic valves.</p>\u0000 <p><b>Methods</b>: A retrospective observational study was conducted by all patients undergoing isolated surgical aortic valve replacement with Mitroflow or Perimount in Western Denmark between 1999 and 2014 and followed until January 2024. The primary endpoint was all-cause mortality. Secondary endpoints were cardiovascular mortality and sudden cardiac death. A propensity score-matched analysis was performed.</p>\u0000 <p><b>Results:</b> A total of 1150 patients were analyzed, with 496 (43%) receiving Mitroflow valves and 654 (57%) receiving Perimount valves. In the Mitroflow group, 108 (22%) had a valve size of 19–21 mm, and 388 (78%) in the size range of 23–29 mm. In the Perimount group, the distribution was 99 (15%) and 555 (85%), respectively. The compromised survival of Mitroflow valves was attributed to the valve type, regardless of the valve sizes. Larger Mitroflow valves exhibited the same compromised late mortality as smaller valves, 66.7% vs 61.5%, respectively (<i>p</i> = 0.95). The same pattern of mortality was observed in the matched population, with Perimount demonstrating significant lower risk of mortality.</p>\u0000 <p><b>Conclusion:</b> Mitroflow valves were associated with a poorer prognosis compared to Perimount valves. Additionally, larger Mitroflow valves were not associated with an improved prognosis compared to smaller valve sizes. EuroSCORE2 had a significant impact on patient survival.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/6712990","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142573981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary Surgical Approaches in Pediatric Aortic Valve Surgery: A Retrospective Comparison of Three Techniques 小儿主动脉瓣手术的当代手术方法:三种技术的回顾性比较
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-10-30 DOI: 10.1155/2024/3783693
R. N. Komarov, D. V. Shumakov, I. I. Chernov, V. A. Belov, V. A. Chragyan, A. M. Ismailbaev, B. M. Tlisov, S. T. Enginoev, B. K. Kadyraliev, V. P. Didyk, M. V. Tarayan, N. O. Kurasov, D. M. Abzalova, Owusu Richmond
{"title":"Contemporary Surgical Approaches in Pediatric Aortic Valve Surgery: A Retrospective Comparison of Three Techniques","authors":"R. N. Komarov,&nbsp;D. V. Shumakov,&nbsp;I. I. Chernov,&nbsp;V. A. Belov,&nbsp;V. A. Chragyan,&nbsp;A. M. Ismailbaev,&nbsp;B. M. Tlisov,&nbsp;S. T. Enginoev,&nbsp;B. K. Kadyraliev,&nbsp;V. P. Didyk,&nbsp;M. V. Tarayan,&nbsp;N. O. Kurasov,&nbsp;D. M. Abzalova,&nbsp;Owusu Richmond","doi":"10.1155/2024/3783693","DOIUrl":"https://doi.org/10.1155/2024/3783693","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Congenital aortic valve (AV) disease is viewed in 2% of the population and in 20 out of 1000 neonates are presented with bicuspid configuration. Treatment of the congenital AV diseases requires multiple interventions. The ultimate goal is to provide adequate close to physiological left ventricle outflow and minimization of regurgitation. The optimal operative management of AV disease in children and young adults remains controversial. AV neocuspidization with glutaraldehyde-treated autologous pericardium may be a satisfactory alternative in pediatric cardiac surgery.</p>\u0000 <p><b>Objectives:</b> The data of the AVNeo procedure results enable a comparative analysis of various AV reconstructive approaches in the pediatric cohort. In this article, we present the comparative study of various techniques in pediatric AV surgery, including the immediate and midterm outcomes of AVNeo, commissurotomy with aortic leaflet augmentation using pericardial patch (“free style” technique), and Ross procedure.</p>\u0000 <p><b>Study Design:</b> We conducted a retrospective analysis of the early and midterm results of surgical AV disease treatment of 44 children in 5 cardiac surgery centers from 2014 to 2022. The patients were divided into 3 groups: group I: glutaraldehyde-treated autologous pericardium AVNeo (<i>n</i> = 12), group II: “free style” technique (<i>n</i> = 10), and group III: Ross procedure (<i>n</i> = 22). We described the immediate and midterm outcomes. The study design was approved by the ethics committees of the participating centers.</p>\u0000 <p><b>Results:</b> A total of 44 children after surgical treatment of the AV disease in 5 cardiac surgery centers were included in the study and were grouped as group I: AVNeo (<i>n</i> = 12), group II: “free style” technique (<i>n</i> = 10), and group III: Ross procedure (<i>n</i> = 22). The median follow-up period was 57 ± 23.8 months. In-hospital mortality was 4.5% (<i>n</i> = 2). In the midterm follow-up, the peak pressure gradient was 18.45 ± 4.63 mmHg for group I and 8.9 ± 1.6 mmHg for group III (<i>p</i> = 0.00001), respectively. The cumulative freedom from reoperations was 100%, 30%, and 95.2% for 40 months of follow-up and 100%, 30%, and 83.4% for 70 months of follow-up in I, II, and III groups, respectively. No cases of midterm mortality were detected in all groups.</p>\u0000 <p><b>Conclusion:</b> The AV neocuspidization with glutaraldehyde-treated autologous pericardium has an enormous advantage in pediatric AV surgery, significantly surpassing the freedom from resurgery of repair procedures and having comparable results with the Ross procedure in the midterm follow-up.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/3783693","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142540981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review and Meta-Analysis of Comparative Studies: Transcatheter Versus Surgical Closure for Postinfarct Ventricular Septal Defect 比较研究的系统回顾和元分析:经导管与手术闭合治疗梗死后室间隔缺损
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-10-30 DOI: 10.1155/2024/8159580
Akira Yamaguchi, Junichi Shimamura, Shinichi Fukuhara, Hiroki Ueyama, Hisato Takagi, Toshiki Kuno
{"title":"Systematic Review and Meta-Analysis of Comparative Studies: Transcatheter Versus Surgical Closure for Postinfarct Ventricular Septal Defect","authors":"Akira Yamaguchi,&nbsp;Junichi Shimamura,&nbsp;Shinichi Fukuhara,&nbsp;Hiroki Ueyama,&nbsp;Hisato Takagi,&nbsp;Toshiki Kuno","doi":"10.1155/2024/8159580","DOIUrl":"https://doi.org/10.1155/2024/8159580","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Postinfarct ventricular septal defect (PIVSD) is a serious complication of acute myocardial infarction (AMI). Transcatheter closure is a potential alternative to surgical closure for PIVSD patients.</p>\u0000 <p><b>Objective:</b> This meta-analysis compares the clinical outcomes of transcatheter closure versus surgical closure for PIVSD.</p>\u0000 <p><b>Methods:</b> A systemic search of PubMed and Embase until January 2023 identified studies comparing transcatheter versus surgical PIVSD closure. Primary outcomes included short-term mortality. Short-term mortality referred to the number of in-hospital or 30-day deaths. Secondary outcomes comprised residual shunt/reintervention incidence, difference in time from AMI or PIVSD diagnosis to intervention, the presence of cardiogenic shock, incidence of perioperative mechanical support, PIVSD size difference, and overall mortality at follow-up.</p>\u0000 <p><b>Results:</b> Seven studies comprising 603 patients were included. Short-term mortality (OR, 1.30; 95% CI [0.90, 1.89]; <i>p</i> = 0.17; <i>I</i><sup>2</sup> <i> = </i>3.0%) did not significantly differ between the two groups. The incidence of residual shunt/reintervention (OR, 3.56; CI, 1.33–9.59; <i>p</i> = 0.01; <i>I</i><sup>2</sup> <i> = </i>63.0%) and PIVSD size (mean difference, −3.94 mm; CI [−6.90, −0.99]; <i>p</i> = 0.09; <i>I</i><sup>2</sup> <i> = </i>83.0%) were significantly different; however, the other secondary outcomes were not significantly different.</p>\u0000 <p><b>Conclusion:</b> Transcatheter and surgical closure demonstrate similar short-term mortality. Despite a higher incidence of residual shunt or reintervention in transcatheter closure, it may be a viable option in patients with small size of PIVSD.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/8159580","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142541011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results 肥厚型心肌病伴二尖瓣瓣叶延长:临床特征和手术结果
IF 1.3 4区 医学
Journal of Cardiac Surgery Pub Date : 2024-10-29 DOI: 10.1155/2024/7078246
Xianying Liu, Daniel McGrath, Kelly Ohlrich, Frederick Y. Chen, Lawrence S. Lee, Michael Robich
{"title":"Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results","authors":"Xianying Liu,&nbsp;Daniel McGrath,&nbsp;Kelly Ohlrich,&nbsp;Frederick Y. Chen,&nbsp;Lawrence S. Lee,&nbsp;Michael Robich","doi":"10.1155/2024/7078246","DOIUrl":"https://doi.org/10.1155/2024/7078246","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.</p>\u0000 <p><b>Methods:</b> This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.</p>\u0000 <p><b>Results:</b> In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, <i>p</i> = 0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, <i>p</i> = 0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, <i>p</i> = 0.006), comparable rates of residual SAM (28.2% vs. 31.5%, <i>p</i> = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, <i>p</i> = 0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, <i>p</i> = 0.409), and mortality (0% vs. 1.0%, <i>p</i> = 0.255).</p>\u0000 <p><b>Conclusions:</b> Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/7078246","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142540825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信